769916-07-6 Usage
General Description
6-bromoquinazoline-4-carboxylic acid is a chemical compound with the molecular formula C9H5BrN2O2. It is a heterocyclic aromatic organic compound with a quinazoline ring and a carboxylic acid functional group. This chemical has potential applications in the pharmaceutical industry, particularly in the development of novel drug compounds. It may also be used as a building block in organic synthesis to create other quinazoline-based compounds. Additionally, it has been studied for its potential biological and pharmacological properties. The presence of the bromine atom makes this compound potentially useful for conducting various chemical reactions and forming diverse derivatives.
Check Digit Verification of cas no
The CAS Registry Mumber 769916-07-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,9,9,1 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 769916-07:
(8*7)+(7*6)+(6*9)+(5*9)+(4*1)+(3*6)+(2*0)+(1*7)=226
226 % 10 = 6
So 769916-07-6 is a valid CAS Registry Number.
InChI:InChI=1/C9H5BrN2O2/c10-5-1-2-7-6(3-5)8(9(13)14)12-4-11-7/h1-4H,(H,13,14)
769916-07-6Relevant articles and documents
SUBSTITUTED IMIDAZOLES FOR THE INHIBITION OF TGF-BETA AND METHODS OF TREATMENT
-
Paragraph 00111; 00113, (2020/03/15)
This disclosure relates to low molecular weight substituted imidazoles that inhibit the TGF-b signaling pathway. More specifically, this disclosure relates to methods of using said imidazoles for the treatment of diseases related to the TGF-b signaling pathways including, but not limited to, atherosclerosis, Marfan syndrome, Loeys-Dietz syndrome, obesity, diabetes, multiple sclerosis, keratoconus, idiopathic pulmonary fibrosis, Alzheimer's Disease, chronic kidney disease, and scleroderma.